DOTA vs NOTA vs DFO

How this supports a project

DOTA, NOTA, and DFO are not interchangeable labels for stronger or weaker chelation. Selection starts with the intended metal and application, then tests complexation kinetics, complex stability, vector compatibility, attachment chemistry, purification, and analysis for the exact derivative.

Match the complete metal-chelator-vector system

DOTA is a tetraaza macrocycle used with several trivalent radiometals and can support imaging or therapy precursor strategies, but complex formation may require heat or longer reaction time depending on the metal and construct. NOTA is a smaller triaza macrocycle whose Ga(III) complexation can be faster under milder conditions than DOTA in direct comparisons. DFO is an acyclic hydroxamate chelator widely used for Zr(IV), especially with antibody-scale vectors and mild labeling conditions.

These are working patterns, not universal assignments. DOTA, NOTA, and DFO can each bind more than one metal, and performance changes with derivative, pH, temperature, chelator concentration, competing metals, buffer, and the attached vector. DFO-Zr complexes also illustrate why common use does not end optimization: higher-denticity DFO derivatives have been investigated to improve Zr coordination and stability.

What changes the decision

Intended metal and time scale

Specify the metal ion or non-radioactive surrogate, oxidation state, intended imaging or therapy role, and the time the complex must remain intact. Do not select from the chelator name alone.

Complexation conditions

Compare pH, buffer, temperature, time, chelator and metal concentration, metal contaminants, and required conversion. A condition suitable for a small peptide may not suit a heat-sensitive protein.

Kinetic and stability evidence

Separate formation rate from thermodynamic and kinetic stability. Confirm the exact metal-chelator complex under the intended challenge and holding conditions.

Bifunctional derivative

Define the chelator derivative, reactive handle, spacer, protecting groups, attachment site, and direction. p-SCN-Bn, activated ester, maleimide, or click-ready derivatives are not process-equivalent.

Vector and loading

Assess conjugation conditions, chelator-to-vector ratio or site occupancy, aggregation, binding or activity retention, and whether added chelator changes charge, hydrophobicity, or clearance-related properties.

Purification and analysis

Plan removal of free chelator and metal, confirmation of identity and chelator loading, complexation yield, radiochemical or cold-complex purity as applicable, stability, and retained vector function.

Information needed for selection

Metal specification

Element, oxidation state, radionuclide or cold surrogate, source form, activity or mass range where relevant, competing metals, and required complex lifetime.

Targeting vector

Exact identity or structure, amount, formulation, available attachment sites, heat and pH tolerance, metal sensitivity, and function that must be retained.

Chelator format

DOTA-, NOTA-, or DFO-family derivative, bifunctional handle, spacer, protection state, salt form, attachment site, and target loading or substitution.

Workflow

Order of chelator installation, purification, storage, metal complexation, hold time, final purification, formulation, and transfer to the qualified radiochemistry team.

Acceptance evidence

Precursor identity and purity, free chelator, chelator-to-vector ratio or site occupancy, aggregation, complexation performance, stability challenge, and retained binding or activity.

Selection and supply boundary

CHEMOS supplies or evaluates selected cold, non-radioactive chelators, bifunctional derivatives, targeting-ligand intermediates, and precursor building blocks. This page does not offer radionuclides, radioactive labeling, radioactive transport, dose preparation, clinical manufacture, dosimetry, imaging or therapeutic performance, safety, or regulatory approval. Final metal-chelator selection and radiochemistry must be qualified by the responsible specialist team.

FAQ

Is one chelator universally best?

No. The exact metal, derivative, complexation conditions, vector, attachment method, required lifetime, purification, and analytical evidence determine suitability.

Does CHEMOS supply radioactive materials?

No. CHEMOS focuses on selected cold, non-radioactive chelators, bifunctional derivatives, intermediates, and precursor building blocks.

Related catalog and technical pages

Radiopharmaceutical chelators and precursorsBrowse cold chelators, bifunctional derivatives, targeting-ligand intermediates, and non-radioactive precursor building blocks.Radiopharmaceutical chelator chemistryReview metal-chelator matching, bifunctional handles, precursor planning, and scope boundaries.Radiopharmaceutical precursor planningDefine the path from intended metal and targeting vector to cold precursor and external radiochemistry.Conjugation chemistry and linkersReview attachment site, spacer, reaction order, purification, and final-conjugate controls.Analytical method supportReview identity, chelator loading, free components, purity, stability, aggregation, and retained-function methods.